22 September 2015 - The political blaze over drug costs that kicked up a year ago over the Hepatitis C cure Sovaldi has moved on to therapies for more diseases—and beyond white heat too. Now Hillary Clinton and others upset with the price of medical progress are proposing government remedies, including price controls.

The anti-Sovaldi protesters claimed they were merely raising questions about the right balance between affordability and innovation, and requesting “transparency” about the relationship between the price of a drug and the cost of development. These subtleties were missed by the many states that are moving to impose administrative pricing schemes.

For more details, go to: http://www.wsj.com/articles/the-assault-on-drug-innovation-1442964103